Literature DB >> 18295739

Scleroderma-like disorders.

R Foti1, R Leonardi, R Rondinone, M Di Gangi, C Leonetti, M Canova, A Doria.   

Abstract

Fibrosing disorders comprise a wide spectrum of heterogeneous diseases characterized by sclerosis of the dermis, subcutis, and sometimes the underlying soft tissues and bone. The hallmark of this group of diseases is skin thickening as in systemic sclerosis with a different distribution pattern and for this reason they have also been referred to as "scleroderma-like" disorders. These diseases may have a different clinical course ranging from a benign disease with a localized cutaneous involvement, to a widespread, systemic, life-threatening disease. Some of them are associated with autoantibodies and/or autoimmune conditions. An accurate recognition of these scleroderma-like diseases is important for the institution of the most appropriate treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18295739     DOI: 10.1016/j.autrev.2007.12.004

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  10 in total

Review 1.  Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.

Authors:  Caterina Ferreli; Giulia Gasparini; Aurora Parodi; Emanuele Cozzani; Franco Rongioletti; Laura Atzori
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 2.  Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future.

Authors:  Luca Cantarini; Donato Rigante; Antonio Vitale; Salvatore Napodano; Lazaros I Sakkas; Dimitrios P Bogdanos; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

3.  Werner's syndrome may be lost in the shadow of the scleroderma.

Authors:  Emel Gonullu; Nazife Sule Yaşar Bilge; Timuçin Kaşifoğlu; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2012-11-06       Impact factor: 2.631

4.  Geographic disparity in systemic sclerosis mortality in the United States: 1999-2017.

Authors:  Alicia Rodriguez-Pla; Robert W Simms
Journal:  J Scleroderma Relat Disord       Date:  2019-08-26

Review 5.  Pathophysiology of gadolinium-associated systemic fibrosis.

Authors:  Brent Wagner; Viktor Drel; Yves Gorin
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-04

6.  Fibrillin assemblies: extracellular determinants of tissue formation and fibrosis.

Authors:  Jacopo Olivieri; Silvia Smaldone; Francesco Ramirez
Journal:  Fibrogenesis Tissue Repair       Date:  2010-12-02

7.  Coexistence of diabetes mellitus type 1 with diffuse systemic sclerosis - case report and literature review.

Authors:  Ewa Wielosz; Maria Kurowska; Dorota Suszek; Maria Majdan
Journal:  Reumatologia       Date:  2017-04-28

8.  Porphyria Cutanea Tarda Presenting with Scleroderma, Ichthyosis, Alopecia, and Vitiligo.

Authors:  Megan E MacGillivray; Thomas G Salopek
Journal:  Case Rep Dermatol       Date:  2018-05-17

9.  Ultrasonographic Findings of Scleredema Adultorum of Buschke Involving the Posterior Neck.

Authors:  Dong-Ho Ha; Myung Jin Lee; Su-Jin Kim
Journal:  Korean J Radiol       Date:  2018-04-06       Impact factor: 3.500

10.  A case of Myhre syndrome mimicking juvenile scleroderma.

Authors:  Barbara Jensen; Rebecca James; Ying Hong; Ebun Omoyinmi; Clarissa Pilkington; Neil J Sebire; Kevin J Howell; Paul A Brogan; Despina Eleftheriou
Journal:  Pediatr Rheumatol Online J       Date:  2020-09-11       Impact factor: 3.413

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.